Clinical Trial Update: Fluvastatin, Rosuvastatin Added to Pegylated Interferon and Ribavirin [Phase 2]

View source ↗

Summary

Phase 2 clinical trial examining adding fluvastatin and rosuvastatin to pegylated interferon and ribavirin for chronic hepatitis C; the study is reported as com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Fluvastatin (fluvastatin)
• Pegylated interferon (pegylated interferon alfa)
• Ribavirin (ribavirin)
• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Bader, Ted, M.D. | Conditions: Chronic Hepatitis C | Phase 2 | Status: COMPLETED